Latest ResMed News & Updates

See the latest news and media coverage for ResMed. We track all announcements, press releases, and industry mentions in real time, all in one place.

ResMed

Medical technology company for sleep and respiratory care

resmed.com

Headquarters: San Diego, United States
Company type: Public company
Number of employees: 9,000–10,000

Last updated Today

Latest news about ResMed

In short: ResMed delivered strong Q3 2026 financial results, completed the $340 million acquisition of Noctrix Health, and appointed a new CFO.

Company announcements

June 1 ResMed

ResMed completes acquisition of Noctrix Health

The deal adds Nidra TOMAC therapy for Restless Legs Syndrome.

May 7 ResMed

ResMed CEO discusses AI and GLP-1 innovations

Mick Farrell highlights AI for personalized sleep experiences via Smart Comfort and DAWN. GLP-1 therapies boost sleep apnea diagnosis and CPAP engagement for 2.1+ million patients.

May 4 ResMed

ResMed announces ENS certification of AirView

The certification, granted after an independent audit, confirms compliance with strict cybersecurity requirements to protect systems and patient data.

April 30 ResMed

ResMed appoints Aaron Bloomer CFO

Brett Sandercock retires effective May 4, 2026; Bloomer joins from Exact Sciences and Sandercock will advise through 2027.

Media coverage

June 17 Seeking Alpha

ResMed stock downgraded at Morgan Stanley (RMD:NYSE) | Seeking Alpha

ResMed (RMD) stock drops as Morgan Stanley downgrades the company, citing GLP-1 drug headwinds and a possible market return of Philips (PHG). Read more here.

June 15 The Globe and Mail

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) was downgraded to a Hold Rating at Morgan Stanley

According to TipRanks, Bailey is a 4-star analyst with an average return of 6.3% and a 43.81% success rate. Bailey covers the Healthcare sector, focusing...

June 15 Yahoo Finance

ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation Signals

Recent performance snapshot ResMed (RMD) has drawn investor attention after a period of mixed share performance, with the stock up about 1% over the past...

June 11 The Bull

ResMed Shares Downgraded: Trimmed Price Target Offers Some Comfort To Bulls - The Bull

ResMed shares (ASX: RMD) have been trading lower in the US session overnight, with the NYSE listed share price down 2% early. The pullback comes...

Never miss news about ResMed

Track ResMed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.